PD-1/PD-L1 antibody therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-1/PD-L1 antibody therapy, covering 2024-08-22 to 2024-08-22. Get the full timeline:
Most recent: Clinical Trial Update: Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma [Phase 2]